MARKET

MCRB

MCRB

Seres Therapeutics Inc
NASDAQ
17.55
-0.35
-1.96%
Opening 11:04 12/05 EST
OPEN
17.78
PREV CLOSE
17.90
HIGH
17.82
LOW
17.43
VOLUME
15.60K
TURNOVER
--
52 WEEK HIGH
29.98
52 WEEK LOW
6.53
MARKET CAP
158.77M
P/E (TTM)
29.79
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MCRB last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at MCRB last week (1117-1121)?
Weekly Report · 11/24 10:18
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 11/20 17:05
Weekly Report: what happened at MCRB last week (1110-1114)?
Weekly Report · 11/17 10:18
Weekly Report: what happened at MCRB last week (1103-1107)?
Weekly Report · 11/10 10:16
Canaccord Genuity Keeps Their Buy Rating on Seres Therapeutics (MCRB)
TipRanks · 11/06 14:47
Seres Therapeutics Reports Positive Q3 2025 Results
TipRanks · 11/06 05:11
Seres Therapeutics Reports Positive Q3 Earnings Call
TipRanks · 11/06 01:20
More
About MCRB
Seres Therapeutics, Inc. is a clinical-stage company focused on improving patient outcomes in medically vulnerable populations through novel live biotherapeutics. It is developing SER-155, which has shown a significant reduction in bloodstream infections and related complications (as compared to placebo) in a Phase 1b clinical study in patients undergoing allo-HSCT and Fast Track designation to reduce the risk of infection and graft-versus-host disease in adults undergoing allo-HSCT. SER-155 and the Company’s other pipeline programs are designed to target multiple disease-relevant pathways. In addition to allo-HSCT, it intends to evaluate SER-155 and other cultivated live biotherapeutic candidates in other medically patient populations, including autologous-HSCT patients, cancer patients with neutropenia, CAR-T recipients, individuals with chronic liver disease, solid organ transplant recipients, as well as patients in the intensive care unit and long-term acute care facilities.

Webull offers Seres Therapeutics Inc stock information, including NASDAQ: MCRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MCRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MCRB stock methods without spending real money on the virtual paper trading platform.